Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NuVasive files IDE

This article was originally published in The Gray Sheet

Executive Summary

IDE filed for NeoDisc cervical nucleus replacement device, the company announces Oct. 24, increasing the device's odds of being the first of its kind to market. NuVasive acquired NeoDisc from AMI Holding's subsidiary Pearsalls in August. The firm plans to market NeoDisc with its Cerpass cervical total disc replacement, for which it filed an IDE in July. NuVasive expects that NeoDisc could reach the U.S. market in 2010 (1"The Gray Sheet" Aug. 8, 2005, p. 15)...
Advertisement

Related Content

Earnings Calls In Brief
NuVasive Nabs Nucleus Replacement Device With $43.5 Mil. Pearsalls’ Buy
NuVasive Nabs Nucleus Replacement Device With $43.5 Mil. Pearsalls’ Buy
Advertisement
UsernamePublicRestriction

Register

MT022844

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel